Ubs Group Ag Aravive, Inc. Transaction History

Ubs Group Ag

  • $397 Billion
  • Q1 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$0.11 - $0.22 $12,208 - $24,416
-110,982 Reduced 61.12%
70,600 $8,000
Q3 2023

Nov 09, 2023
BUY
$0.11 - $1.76 $10,558 - $168,937
95,987 Added 112.14%
181,582 $23,000
Q2 2023

Aug 11, 2023
BUY
$1.25 - $1.92 $66,976 - $102,875
53,581 Added 167.37%
85,595 $107,000
Q1 2023

May 12, 2023
BUY
$1.29 - $2.46 $7,758 - $14,794
6,014 Added 23.13%
32,014 $64,000
Q2 2022

Aug 10, 2022
SELL
$0.93 - $1.9 $13,950 - $28,500
-15,000 Reduced 36.59%
26,000 $26,000
Q1 2022

May 16, 2022
SELL
$1.85 - $2.75 $17,935 - $26,661
-9,695 Reduced 19.12%
41,000 $79,000
Q4 2021

Feb 14, 2022
SELL
$2.19 - $4.07 $16,523 - $30,708
-7,545 Reduced 12.96%
50,695 $111,000
Q3 2021

Nov 15, 2021
SELL
$3.67 - $5.8 $50,693 - $80,115
-13,813 Reduced 19.17%
58,240 $217,000
Q2 2021

Aug 13, 2021
SELL
$4.65 - $6.42 $24,026 - $33,172
-5,167 Reduced 6.69%
72,053 $431,000
Q1 2021

May 12, 2021
BUY
$5.11 - $9.24 $12,923 - $23,367
2,529 Added 3.39%
77,220 $509,000
Q4 2020

Feb 11, 2021
BUY
$4.36 - $6.51 $7,002 - $10,455
1,606 Added 2.2%
74,691 $421,000
Q3 2020

Nov 12, 2020
SELL
$4.7 - $12.06 $36,857 - $94,574
-7,842 Reduced 9.69%
73,085 $343,000
Q2 2020

Jul 31, 2020
BUY
$5.18 - $14.81 $5,609 - $16,039
1,083 Added 1.36%
80,927 $942,000
Q1 2020

May 01, 2020
SELL
$3.5 - $13.77 $7,392 - $29,082
-2,112 Reduced 2.58%
79,844 $460,000
Q4 2019

Feb 14, 2020
BUY
$6.21 - $14.02 $99,061 - $223,647
15,952 Added 24.17%
81,956 $1.12 Million
Q3 2019

Nov 14, 2019
SELL
$5.2 - $8.68 $8,912 - $14,877
-1,714 Reduced 2.53%
66,004 $495,000
Q2 2019

Aug 14, 2019
BUY
$5.65 - $7.5 $66,749 - $88,605
11,814 Added 21.13%
67,718 $406,000
Q1 2019

May 14, 2019
BUY
$3.35 - $8.27 $74,916 - $184,942
22,363 Added 66.67%
55,904 $394,000
Q4 2018

Feb 14, 2019
BUY
$3.23 - $8.7 $108,337 - $291,806
33,541 New
33,541 $118,000

Others Institutions Holding ARAV

# of Institutions
4
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Aravive, Inc.

ARAV Quotes by TradingView
  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email